Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 1R01HL153386 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | NIH |
Not provided
Not provided
Not provided
The investigators will attempt to develop a more accurate equation to estimate eGFR in pediatric and adult sickle cell patients
200 pediatric and 200 adult SCA participants will undergo mGFR using iohexol at baseline and at one year. On the same day, participants will undergo clinical and laboratory variables important for developing an eGFR equation. From baseline data, the investigators will perform a training and validation cohort of biologically relevant predictor variables to develop a novel equation. Then the investigators will compare the novel SCA eGFR equation to the established eGFR equation. From one year data, the investigators will determine the longitudinal concordance between pediatric and adult novel and standard eGFR equations with mGFR and variables that may alter longitudinal inferences.
In a subset of 30 adult participants, the investigators will also evaluate the correlation between mGFR using iohexol and a novel measure of mGFR that is more time efficient
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pediatric SCA | We will develop a novel eGFR equation in 200 pediatric participants |
| |
| Adult SCA | We will develop a novel eGFR equation in 200 adult participants |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| iohexol GFR | Diagnostic Test | We will perform mGFR in 400 SCA patients |
|
| Measure | Description | Time Frame |
|---|---|---|
| To develop a novel SCA-specific eGFR equation and compare with existing eGFR equations validated for the general population | The investigators will use biologically relevant variables to develop a new equation for eGFR in pediatric and adult sickle cell patients | 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| To determine the longitudinal concordance between pediatric and adult novel and standard eGFR equations with mGFR and variables that may alter longitudinal inferences. | To compare the concordance between eGFR and mGFR from baseline to one year | 5 years |
| To test the correlation of the novel mGFR method using VFI FAST and iohexol mGFR. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Patients with sickle cell anemia
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jeffrey Lebensburger, DO, MSPH | University of Alabama at Birmingham | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35223 | United States | ||
| University of Illinois Chicage |
Data collected in this study will be made available to other researchers, after the goals have been met and primary aims have been published. Disclosure of sensitive health and behavior data present a potential risk to human subjects, and we will take all steps to ensure that this does not happen when data are shared. In addition, we will strongly recommend that all recipient groups ensure that every member of the staff sign a Confidentiality Agreement. We will develop a data and resource sharing agreement with the legal advice from the Compliance Office of the UAB. Before data is shared with researchers, we will require that researchers enter into a data- and resource-sharing agreement. This agreement will ensure that: 1) data are used only for research purposes; 2) data do not identify any individual participant; 3) data are secure, using appropriate computer technology; and 4) there is a commitment to destroy or return data after analyses are completed.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Jun 16, 2026 |
| ID | Term |
|---|---|
| D000755 | Anemia, Sickle Cell |
| D007674 | Kidney Diseases |
| ID | Term |
|---|---|
| D000745 | Anemia, Hemolytic, Congenital |
| D000743 | Anemia, Hemolytic |
| D000740 | Anemia |
| D006402 | Hematologic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
To perform a 3 hour mGFR and compare this mGFR to the 6 hour mGFR (iohexol) |
| 5 years |
| Chicago |
| Illinois |
| 60612 |
| United States |
| St Jude Childrens Research Hospital | Memphis | Tennessee | 38106 | United States |
| University of Tennessee Health Science Center | Memphis | Tennessee | 38163 | United States |
| D006425 |
| Hemic and Lymphatic Diseases |
| D006453 | Hemoglobinopathies |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |